Pulmonx (LUNG) Long-Term Investments (2021 - 2024)

Pulmonx (LUNG) has 4 years of Long-Term Investments data on file, last reported at $4.3 million in Q1 2024.

• On a quarterly basis, Long-Term Investments rose 62.8% year-over-year to $4.3 million in Q1 2024; TTM through Mar 2024 was $4.3 million, a 62.8% increase from a year earlier, with the FY2023 full-year figure at $14.4 million, up 142.91% from the prior year.
• Long-Term Investments for Q1 2024 stood at $4.3 million, down from $14.4 million in the prior quarter.
• Over the last five years, Long-Term Investments for LUNG reached as high as $23.3 million in Q3 2023 and fell as low as $2.0 million in Q2 2021.
• Historically, Long-Term Investments has averaged $7.7 million across 4 years, with a median of $5.3 million in 2022.
• On a YoY basis, Long-Term Investments climbed as much as 165.88% in 2023 and fell as far as 58.66% in 2023.
• Year by year, Long-Term Investments stood at $10.9 million in 2021, then sank by 45.86% to $5.9 million in 2022, then jumped by 142.91% to $14.4 million in 2023, then plunged by 70.17% to $4.3 million in 2024.
• Per Business Quant data, the three most recent Long-Term Investments figures were $4.3 million in Q1 2024, $14.4 million in Q4 2023, and $23.3 million in Q3 2023.